Symbols / BLRX $2.32 -0.55% BioLineRx Ltd.

Healthcare • Biotechnology • Israel • NCM
BLRX Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Fundamentals
Scroll to Statements
Market Cap 10.43M Enterprise Value 6.08B Income -1.18M Sales 1.18M Book/sh 4.20 Cash/sh 0.01
Dividend Yield — Payout 0.00% Employees 20 IPO — P/E inf Forward P/E -3.46
PEG — P/S 8.84 P/B 0.55 P/C — EV/EBITDA -604.14 EV/Sales 5150.53
Quick Ratio 1.76 Current Ratio 1.95 Debt/Eq 43.48 LT Debt/Eq — EPS (ttm) 0.00 EPS next Y -0.67
EPS Growth — Revenue Growth -98.30% Earnings 2026-05-27 ROA -16.11% ROE -11.01% ROIC —
Gross Margin 80.51% Oper. Margin -17.45% Profit Margin -99.58% Shs Outstand 4.35M Shs Float 2.50B Short Float 3.77%
Short Ratio 11.26 Short Interest — 52W High 7.77 52W Low 2.15 Beta 0.48 Avg Volume 14.35K
Volume 20.72K Target Price $17.50 Recom Strong_buy Prev Close $2.33 Price $2.32 Change -0.55%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$17.50
Mean price target
2. Current target
$2.32
Latest analyst target
3. DCF / Fair value
$-16.03
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.32
Low
$12.00
High
$23.00
Mean
$17.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-06-17 reit HC Wainwright & Co. Buy → Buy $26
2025-05-30 up Jones Trading Hold → Buy $12
2025-05-28 reit HC Wainwright & Co. Buy → Buy $26
2025-04-02 down Jones Trading Buy → Hold —
2025-03-31 main HC Wainwright & Co. Buy → Buy $26
2024-11-25 main HC Wainwright & Co. Buy → Buy $9
2024-11-06 reit HC Wainwright & Co. Buy → Buy $21
2024-06-03 reit HC Wainwright & Co. Buy → Buy $21
2024-05-29 reit HC Wainwright & Co. Buy → Buy $21
2024-04-17 reit HC Wainwright & Co. Buy → Buy $21
2024-03-26 reit HC Wainwright & Co. Buy → Buy $21
2024-02-29 reit HC Wainwright & Co. Buy → Buy $21
2023-11-20 reit HC Wainwright & Co. Buy → Buy $21
2023-09-15 main HC Wainwright & Co. Buy → Buy $21
2023-08-31 reit HC Wainwright & Co. Buy → Buy $19
2023-05-25 reit Oppenheimer — → Outperform $4
2021-02-23 main HC Wainwright & Co. — → Buy $19
2020-12-16 main HC Wainwright & Co. — → Buy $22
2017-08-04 init Oppenheimer — → Outperform $3
2017-05-18 up Maxim Group Hold → Buy —
News
RSS: Latest BLRX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1.18
-95.92%
28.94
+502.92%
4.80
0.00
Operating Revenue
1.18
-95.92%
28.94
+502.92%
4.80
0.00
Cost Of Revenue
0.23
-97.52%
9.26
+150.89%
3.69
0.00
Reconciled Cost Of Revenue
0.23
-95.85%
5.54
+108.27%
2.66
0.00
Gross Profit
0.95
-95.17%
19.68
+1675.90%
1.11
0.00
Operating Expense
11.24
-71.06%
38.83
-11.95%
44.10
+51.25%
29.16
Research And Development
8.09
-11.54%
9.15
-26.92%
12.52
-28.99%
17.63
Selling General And Administration
3.92
-86.28%
28.54
-8.61%
31.23
+171.82%
11.49
Selling And Marketing Expense
0.00
-100.00%
10.08
-30.92%
14.59
+198.89%
4.88
General And Administrative Expense
3.92
-78.79%
18.46
+10.96%
16.64
+151.81%
6.61
Salaries And Wages
1.70
-88.60%
14.91
+19.10%
12.52
+241.97%
3.66
Other Gand A
1.61
-41.20%
2.75
-13.73%
3.18
+67.39%
1.90
Total Expenses
11.47
-76.16%
48.09
+0.63%
47.79
+63.91%
29.16
Operating Income
-10.29
+46.29%
-19.15
+55.45%
-42.99
-47.45%
-29.16
Total Operating Income As Reported
-10.29
+49.59%
-20.41
+58.93%
-49.69
-70.44%
-29.16
EBITDA
-0.25
-106.43%
3.92
+106.86%
-57.09
-153.59%
-22.51
Normalized EBITDA
-9.19
+33.60%
-13.84
+64.86%
-39.39
-37.78%
-28.59
Reconciled Depreciation
0.52
-87.13%
4.07
+193.71%
1.38
+111.62%
0.65
EBIT
-0.78
-427.21%
-0.15
+99.75%
-58.47
-152.41%
-23.16
Total Unusual Items
8.94
-49.67%
17.76
+200.36%
-17.70
-391.10%
6.08
Total Unusual Items Excluding Goodwill
8.94
-49.67%
17.76
+200.36%
-17.70
-391.10%
6.08
Special Income Charges
0.00
+100.00%
-1.26
+81.26%
-6.70
0.00
Other Special Charges
—
0.25
—
—
Impairment Of Capital Assets
0.00
-100.00%
1.01
-84.93%
6.70
0.00
Net Income
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Pretax Income
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Non Operating Interest Income Expense
-0.16
+97.86%
-7.30
-4405.56%
-0.16
+85.51%
-1.12
Interest Expense Non Operating
1.25
-86.21%
9.07
+323.23%
2.14
+20.04%
1.79
Net Interest Income
-0.16
+97.86%
-7.30
-4405.56%
-0.16
+85.51%
-1.12
Interest Expense
1.25
-86.21%
9.07
+323.23%
2.14
+20.04%
1.79
Interest Income Non Operating
1.12
-38.24%
1.82
-9.32%
2.01
+189.19%
0.69
Interest Income
1.12
-38.24%
1.82
-9.32%
2.01
+189.19%
0.69
Other Income Expense
8.42
-51.15%
17.23
+198.68%
-17.46
-427.97%
5.32
Other Non Operating Income Expenses
-0.52
+1.51%
-0.53
-325.53%
0.23
+131.13%
-0.76
Gain On Sale Of Security
8.94
-52.99%
19.02
+272.98%
-10.99
-280.84%
6.08
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Income From Continuing Operation Net Minority Interest
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Income From Continuing And Discontinued Operation
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Income Continuous Operations
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Minority Interests
0.85
—
—
—
Normalized Income
-10.11
+62.51%
-26.98
+37.13%
-42.92
-38.31%
-31.03
Net Income Common Stockholders
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Diluted EPS
0.00
+100.00%
-6.00
+83.33%
-36.00
-100.00%
-18.00
Basic EPS
0.00
+100.00%
-6.00
+83.33%
-36.00
-100.00%
-18.00
Basic Average Shares
4.11
+105.76%
2.00
+24.37%
1.61
+24.47%
1.29
Diluted Average Shares
4.11
+105.76%
2.00
+24.37%
1.61
+24.47%
1.29
Diluted NI Availto Com Stockholders
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Depreciation Amortization Depletion Income Statement
0.03
-91.76%
0.34
-3.13%
0.35
+800.00%
0.04
Depreciation And Amortization In Income Statement
0.03
-91.76%
0.34
-3.13%
0.35
+800.00%
0.04
Depreciation Income Statement
0.03
-91.76%
0.34
-3.13%
0.35
+800.00%
0.04
Insurance And Claims
0.60
-25.37%
0.81
-13.95%
0.94
-10.23%
1.05
Provision For Doubtful Accounts
-0.80
-200.00%
0.80
0.00
0.00
Total Other Finance Cost
0.03
-35.56%
0.04
+80.00%
0.03
-3.85%
0.03
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
40.91
+5.14%
38.91
-39.14%
63.92
-16.31%
76.38
Current Assets
23.68
-12.63%
27.10
-42.56%
47.18
-9.27%
52.00
Cash Cash Equivalents And Short Term Investments
20.88
+6.72%
19.56
-54.50%
42.99
-15.83%
51.08
Cash And Cash Equivalents
3.25
-68.86%
10.44
+145.26%
4.25
-59.81%
10.59
Cash Equivalents
2.62
-72.42%
9.49
+762.13%
1.10
-84.19%
6.96
Cash Financial
0.63
-33.05%
0.94
-70.07%
3.15
-12.95%
3.62
Other Short Term Investments
17.63
+93.14%
9.13
-76.44%
38.74
-4.34%
40.49
Receivables
0.46
-88.20%
3.86
+445.62%
0.71
-1.80%
0.72
Accounts Receivable
0.05
-98.14%
2.48
+591.62%
0.36
0.00
Other Receivables
0.41
-70.44%
1.39
+296.29%
0.35
-51.46%
0.72
Inventory
2.15
-31.70%
3.15
+61.03%
1.95
0.00
Raw Materials
—
0.00
-100.00%
0.90
0.00
Work In Process
—
2.98
+532.70%
0.47
0.00
Finished Goods
—
0.17
-71.50%
0.58
0.00
Prepaid Assets
0.20
-62.36%
0.53
-65.05%
1.53
+671.72%
0.20
Total Non Current Assets
17.22
+45.94%
11.80
-29.51%
16.74
-31.34%
24.38
Net PPE
0.86
-36.73%
1.35
-28.34%
1.89
-24.42%
2.50
Gross PPE
5.96
-5.91%
6.33
-14.75%
7.43
+2.03%
7.28
Accumulated Depreciation
-5.10
-2.47%
-4.98
+10.13%
-5.54
-15.85%
-4.78
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.80
-31.86%
1.17
-30.20%
1.68
+9.15%
1.54
Other Properties
1.57
+0.00%
1.57
-2.60%
1.61
+0.44%
1.61
Leases
3.59
+0.00%
3.59
-13.21%
4.13
+0.00%
4.13
Goodwill And Other Intangible Assets
16.37
+56.65%
10.45
-29.66%
14.85
-32.13%
21.89
Other Intangible Assets
16.37
+56.65%
10.45
-29.66%
14.85
-32.13%
21.89
Total Liabilities Net Minority Interest
17.56
-30.99%
25.45
-49.81%
50.70
+98.50%
25.54
Current Liabilities
12.12
-21.31%
15.41
-63.99%
42.78
+300.64%
10.68
Payables And Accrued Expenses
4.93
-40.53%
8.28
-39.99%
13.80
+65.64%
8.33
Payables
4.03
-27.80%
5.58
-49.05%
10.96
+55.42%
7.05
Accounts Payable
3.49
-37.44%
5.58
-48.63%
10.87
+56.03%
6.97
Other Payable
0.54
—
0.09
+4.76%
0.08
Current Accrued Expenses
0.90
-66.85%
2.70
-5.13%
2.85
+121.82%
1.28
Pensionand Other Post Retirement Benefit Plans Current
0.31
-28.07%
0.43
+2.86%
0.42
+11.14%
0.38
Current Debt And Capital Lease Obligation
4.71
-5.76%
5.00
+36.16%
3.67
+86.54%
1.97
Current Debt
4.48
+0.00%
4.48
+42.42%
3.15
+103.96%
1.54
Other Current Borrowings
4.48
+0.00%
4.48
+42.42%
3.15
+103.96%
1.54
Current Capital Lease Obligation
0.23
-55.17%
0.52
-1.14%
0.53
+23.65%
0.43
Current Deferred Liabilities
—
0.00
-100.00%
12.96
0.00
Current Deferred Revenue
—
0.00
-100.00%
12.96
0.00
Other Current Liabilities
2.17
+28.56%
1.69
-85.83%
11.93
—
Total Non Current Liabilities Net Minority Interest
5.44
-45.84%
10.04
+26.79%
7.92
-46.73%
14.86
Long Term Debt And Capital Lease Obligation
5.44
-45.84%
10.04
+26.79%
7.92
-23.53%
10.36
Long Term Debt
4.46
-50.21%
8.96
+35.15%
6.63
-23.16%
8.63
Long Term Capital Lease Obligation
0.98
-9.62%
1.08
-16.20%
1.29
-25.39%
1.73
Stockholders Equity
18.20
+35.18%
13.46
+1.80%
13.22
-73.99%
50.84
Common Stock Equity
18.20
+35.18%
13.46
+1.80%
13.22
-73.99%
50.84
Capital Stock
73.43
+92.74%
38.10
+21.50%
31.36
+15.70%
27.10
Common Stock
73.43
+92.74%
38.10
+21.50%
31.36
+15.70%
27.10
Share Issued
2,610.81
+95.32%
1,336.67
+23.02%
1,086.59
+17.73%
922.96
Ordinary Shares Number
2,610.81
+95.32%
1,336.67
+23.02%
1,086.59
+17.73%
922.96
Additional Paid In Capital
327.58
-7.38%
353.69
-0.50%
355.48
+4.87%
338.98
Retained Earnings
-401.00
-0.29%
-399.83
-2.36%
-390.61
-18.37%
-329.99
Gains Losses Not Affecting Retained Earnings
14.50
-10.11%
16.13
+3.51%
15.58
+16.74%
13.35
Minority Interest
5.15
0.00
—
—
Other Equity Adjustments
14.50
-10.11%
16.13
+3.51%
15.58
+16.74%
13.35
Total Equity Gross Minority Interest
23.34
+73.43%
13.46
+1.80%
13.22
-73.99%
50.84
Total Capitalization
22.66
+1.06%
22.42
+12.94%
19.85
-66.62%
59.47
Working Capital
11.56
-1.20%
11.70
+165.92%
4.40
-89.35%
41.32
Invested Capital
27.14
+0.88%
26.90
+16.97%
23.00
-62.31%
61.01
Total Debt
10.15
-32.51%
15.04
+29.76%
11.59
-5.95%
12.32
Net Debt
5.69
+89.57%
3.00
-45.61%
5.52
—
Capital Lease Obligations
1.21
-24.45%
1.60
-11.83%
1.82
-15.68%
2.16
Net Tangible Assets
1.83
-39.31%
3.01
+284.67%
-1.63
-105.63%
28.96
Tangible Book Value
1.83
-39.31%
3.01
+284.67%
-1.63
-105.63%
28.96
Derivative Product Liabilities
—
—
11.93
+164.63%
4.51
Other Equity Interest
3.69
-31.32%
5.37
+281.18%
1.41
+0.00%
1.41
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.07
+81.60%
-43.87
-94.06%
-22.61
+13.84%
-26.24
Cash Flow From Continuing Operating Activities
-8.07
+81.60%
-43.87
-94.06%
-22.61
+13.84%
-26.24
Net Income From Continuing Operations
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Depreciation Amortization Depletion
0.52
-87.13%
4.07
+193.71%
1.38
+111.62%
0.65
Depreciation And Amortization
0.52
-87.13%
4.07
+193.71%
1.38
+111.62%
0.65
Other Non Cash Items
0.02
+101.91%
-0.94
-180.91%
1.16
+161.35%
0.45
Stock Based Compensation
0.40
-65.11%
1.14
-51.10%
2.32
+3.39%
2.25
Asset Impairment Charge
0.00
-100.00%
1.26
-81.26%
6.70
0.00
Operating Gains Losses
-8.24
+55.07%
-18.35
-263.31%
11.24
+291.38%
-5.87
Gain Loss On Investment Securities
-7.90
+56.84%
-18.30
-265.51%
11.05
+276.75%
-6.25
Net Foreign Currency Exchange Gain Loss
-0.37
-601.89%
-0.05
-129.12%
0.18
-52.48%
0.38
Gain Loss On Sale Of PPE
0.03
0.00
0.00
—
Change In Working Capital
1.26
+105.77%
-21.82
-243.55%
15.20
+1127.71%
1.24
Change In Receivables
2.43
+214.73%
-2.12
-491.62%
-0.36
0.00
Changes In Account Receivables
2.43
+214.73%
-2.12
-491.62%
-0.36
0.00
Change In Inventory
1.00
+183.64%
-1.19
+38.97%
-1.95
0.00
Change In Prepaid Assets
1.31
+3146.51%
-0.04
+95.52%
-0.96
-47.54%
-0.65
Change In Payables And Accrued Expense
-3.48
+36.86%
-5.51
-199.93%
5.51
+191.95%
1.89
Change In Other Working Capital
—
-12.96
-200.00%
12.96
—
Investing Cash Flow
-8.54
-129.09%
29.37
+1934.21%
1.44
-63.95%
4.01
Cash Flow From Continuing Investing Activities
-8.54
-129.09%
29.37
+1934.21%
1.44
-63.95%
4.01
Net PPE Purchase And Sale
-0.03
+52.83%
-0.05
+54.31%
-0.12
+11.45%
-0.13
Purchase Of PPE
-0.03
+52.83%
-0.05
+54.31%
-0.12
+11.45%
-0.13
Capital Expenditure
-0.03
+50.00%
-0.05
+81.82%
-0.30
+6.01%
-0.32
Net Investment Purchase And Sale
-8.52
-128.95%
29.43
+1590.29%
1.74
-59.72%
4.32
Purchase Of Investment
-36.64
-39.07%
-26.35
+44.63%
-47.59
-8.15%
-44.00
Sale Of Investment
28.13
-49.58%
55.78
+13.07%
49.33
+2.08%
48.32
Net Intangibles Purchase And Sale
-0.00
-100.00%
-0.00
+99.45%
-0.18
+2.16%
-0.18
Purchase Of Intangibles
-0.00
-100.00%
-0.00
+99.45%
-0.18
+2.16%
-0.18
Financing Cash Flow
8.88
-56.99%
20.66
+37.21%
15.06
-26.33%
20.44
Cash Flow From Continuing Financing Activities
8.88
-56.99%
20.66
+37.21%
15.06
-26.33%
20.44
Net Issuance Payments Of Debt
-5.01
-217.08%
4.28
+315.24%
-1.99
-132.73%
6.07
Issuance Of Debt
0.00
-100.00%
19.22
0.00
-100.00%
9.13
Repayment Of Debt
-5.01
+66.47%
-14.94
-651.71%
-1.99
+34.86%
-3.05
Long Term Debt Issuance
0.00
-100.00%
19.22
0.00
-100.00%
9.13
Long Term Debt Payments
-0.51
-0.20%
-0.51
-14.83%
-0.45
+85.42%
-3.05
Net Long Term Debt Issuance
-0.51
-102.74%
18.71
+4304.94%
-0.45
-107.33%
6.07
Short Term Debt Payments
-4.50
+68.84%
-14.43
-835.39%
-1.54
—
Net Short Term Debt Issuance
-4.50
+68.84%
-14.43
-835.39%
-1.54
—
Net Common Stock Issuance
13.89
-15.06%
16.36
+16.10%
14.09
-1.88%
14.36
Proceeds From Stock Option Exercised
0.00
-100.00%
0.02
-99.26%
2.96
+59000.00%
0.01
Changes In Cash
-7.74
-225.59%
6.16
+200.83%
-6.11
-240.09%
-1.80
Effect Of Exchange Rate Changes
0.55
+2395.45%
0.02
+109.82%
-0.22
+63.10%
-0.61
Beginning Cash Position
10.44
+145.26%
4.25
-59.81%
10.59
-18.50%
12.99
End Cash Position
3.25
-68.86%
10.44
+145.26%
4.25
-59.81%
10.59
Free Cash Flow
-8.10
+81.56%
-43.93
-91.78%
-22.91
+13.75%
-26.56
Interest Paid Supplemental Data
1.27
-87.79%
10.39
+834.92%
1.11
+87.35%
0.59
Common Stock Issuance
13.89
-15.06%
16.36
+16.10%
14.09
-1.88%
14.36
Issuance Of Capital Stock
13.89
-15.06%
16.36
+16.10%
14.09
-1.88%
14.36
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category